Aerie pharmaceuticals to participate in the raymond james human health innovation conference – updated release

Durham, n.c.--(business wire)--aerie pharmaceuticals, inc. (nasdaq: aeri), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced that vicente anido, jr., ph.d., chairman and chief executive officer, will present in a fireside discussion at the raymond james human health innovation conference on tuesday, june
AERI Ratings Summary
AERI Quant Ranking